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 Summary
  Pulmonary emphysema, together with chronic bronchitis is a part of chronic obstructive 
pulmonary disease (COPD), which is one of the leading causes of death in the United States and 
worldwide. There are many methods to diagnose emphysema. Unfortunately many of them, 
for example pulmonary function tests (PFTs), clinical signs and conventional radiology are able 
to detect emphysema usually in its late stages when a great portion of lung parenchyma has 
been already destroyed by the disease. Computed tomography (CT) allows for early detection of 
emphysema. CT also makes it possible to quantify the total amount of emphysema in the lungs 
which is important in order to precisely estimate the severity of the disease. Those abilities of 
CT are important in monitoring the course of the disease and in attempts to prevent its further 
progression. In this review we discuss currently available methods for imaging emphysema with 
emphasis on the quantitative assessment of emphysema. To date, quantitative methods have not 
been widely used clinically, however, the initial results of several research studies regarding this 
subject are very encouraging.
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According to the National Heart, Lung, and Blood Institute, 
emphysema is a “condition of the lung characterized by 
abnormal, permanent enlargement of the airspaces distal 
to the terminal bronchiole, accompanied by destruction of 
their walls” [1].
Pulmonary emphysema, together with chronic bronchitis 
is a part of COPD – chronic obstructive pulmonary disease. 
A US Centers for Disease Control and Prevention (CDC) 
Morbidity Mortality Weekly Report study of the National 
Vital Statistics System reported an age-standardized death 
rate from COPD in the United States for adults older than 
25 years of 64.3 deaths per 100,000 population [2]. COPD 
remains one of the leading causes of mortality in the USA 
and worldwide. The incidence of emphysema seems to have 
a strong correlation with the cigarette smoking. In one 
of the studies on this subject Remy-Jardin et al. showed 
that in smokers who underwent pulmonary lobe resec-
tion because of the presence of nodules there was a high 
incidence of emphysema seen in pathologic specimen, even 
with no apparent clinical symptoms and with no obstruc-
tion of the airways [3]. The National Health Interview 
Survey reports the prevalence of emphysema at 1.8% [4].
There are two main types of emphysema, depending on mor-
phologic appearance and areas of lung parenchyma destruc-
tion in regards to a secondary pulmonary lobule. The centri-
acinar (centrilobular) type is usually associated with destruc-
tion of alveolar walls in the central portion of acinus, it is 
more often found in upper lung zones (upper lobes – poste-
rior and apical segments or superior segments of lower lobes) 
and is commonly associated with cigarette smoking [5]. The 
panacinar (panlobular) type is recognized as a destruction 
involving all portions of the lobule out to the periphery. This 
form is often found in alfa-1-antitrypsin deficiency and has 
a marked predilection to lower lobes [5]. In more severe dis-
ease these two subtypes can appear side by side but usually 
one of them predominates and the distinction between these 
two can be sometimes very difficult or even impossible. 
Additionally two more subtypes of emphysema have been 
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identified. Paraseptal form which can appear as an isolated 
finding but is usually found together with severe centriaci-
nar or panacinar emphysema. This type occurs in the periph-
ery of the lung, close to the pleura or interlobular septa. Its 
most characteristic feature is presence of bullae – single or 
multiple, well-demarcated, air-filled cysts of 1 cm or more 
in diameter and smooth, thin (less than 1mm) walls. Another 
subtype is called paracicatricial and this form is associated 
with areas of scarring in the lung.
Unfortunately, early emphysema is usually asymptomatic 
for a long time and more than 30% of the total lung paren-
chyma has to be destroyed in order for the clinical symp-
toms to be present or changes in pulmonary function tests 
(PFTs) to appear [6]. That is why in order to understand the 
presence and severity of emphysema all clinical features, 
laboratory data and imaging studies should be gathered 
and assessed together.
In this review we discuss currently available and used 
methods of visualization of emphysema with emphasis on 
newer and promising approaches to quantitative analy-
sis of pulmonary emphysema in vivo, especially by using 
widely available Computed Tomography (CT).
Chest Radiography
Chest X-ray (CXR) has been the most routinely used method 
for diagnostic imaging of the lungs in patients with COPD.
The most specific feature of emphysema on CXR is the 
presence of bullae. The more severe the emphysema, the 
more likely radiological diagnosis will be made based just 
on the CXR. The characteristic features of emphysema 
which can be seen on the routine CXR include: lowering 
and flattening of diaphragm, increased antero-posterior 
diameter of the chest (retrosternal space of more than 2.5 
cm in front of the ascending aorta on the lateral view), 
presence of bullae/blebs, “saber-sheath trachea”, “increased 
lung markings” (probably due to bronchial wall thicken-
ing associated with inflammatory changes) or the paucity 
of pulmonary vessels in the peripheral lungs. Emphysema 
with increased markings is found especially in patients 
with cor pulmonale. The presence of peripheral arterial 
deficiency has a low sensitivity but high specificity [5,7]. 
In the study conducted by Lohela et al. [8] the research-
ers compared the signs of emphysema on a routine chest 
radiograph to the post-mortem evidence of the disease. The 
main conclusion from the study was that if two or more of 
the signs of emphysema (according to criteria established 
by the authors) were present on CXR, a total accuracy of 
77% in detecting the disease was achieved. The mean num-
ber of radiologic signs increased with the severity of mor-
phologic emphysema. Overall, the sensitivity of chest radi-
ography is low, especially in mild to moderate disease.
Computed Tomography
With the shortcomings of conventional radiography, CT has 
become the more reliable and widely used and investigated 
imaging tool for the assessment of pulmonary emphysema. 
Currently, CT, and specifically high-resolution CT (HRCT) 
are the methods of choice to diagnose emphysema in vivo. 
Because of higher spatial resolution HRCT is a preferred tool 
to visually detect especially small areas of emphysema [9].
Centrilobular emphysema which more often involves 
upper parts of the lungs, is usually described as the irreg-
ular, small, round or confluent areas of low attenuation 
interspersed with a normal lung. The localization near 
the center of a secondary pulmonary lobule is also typi-
cal. Panacinar emphysema is found mainly in the lower 
zones of the lungs. It is usually seen as the diffuse areas 
of low attenuation with little normal lung tissue between 
the lesions. In severe panacinar emphysema diffuse/
widespread areas of lung parenchyma with low attenua-
tion and significantly decreased vascular markings might 
be seen. This picture is also known as a “simplification of 
lung parenchyma” and when present helps to separate nor-
mal lung parenchyma from emphysema. Mild or moder-
ate panacinar emphysema might be often very difficult, or 
even impossible to distinguish from adjacent normal lung 
parenchyma on CT scans [7].
Quantitative Assessment by CT (QCT)
CT proved to be not just a great method to detect emphy-
sema but also a tool to estimate the extent and sever-
ity of this disease. The qualitative subjective evaluation of 
emphysema performed by a radiologist can be augmented 
with the objective quantitative assessment by CT, by den-
sity measurements or more recently, by postprocessing of 
CT data and texture analysis. For subjective assessment 
of emphysema HRCT is of great use, but when it comes to 
objective densitometric studies, the combination of thin 
sections and the high spatial frequency algorithm (also 
known as the edge-enhancing, sharp algorithm) results in 
poor density resolution, and therefore should be avoided [9].
Initially the diagnosis of pulmonary emphysema on CT 
scans was greatly dependent on subjective, visual assess-
ment of a radiologist.
Multiple studies, for example by Bergin et al. [10], Hruban 
et al. [11], Miller et al. [12] and Kuwano et al. [13], were 
conducted to compare the presence and the degree of 
emphysema on CT images with corresponding pathologi-
cal data. They showed that there was a good correlation 
between radiological visual assessment and pathological 
report at the same/comparable lung fragment. With using 
various section thickness (1–10 mm), depending on the 
study, the correlation coefficients ranged from 0.6 to 0.8. 
However, Miller et al. also showed that it could be difficult 
to detect the earliest forms of pulmonary emphysema on 
CT scans because of the small sizes of those lesions, often 
less than 5 mm in diameter. Therefore, they were usually 
missed on CT scans. This study also reported that qualita-
tive evaluation of CT scans consistently underestimated the 
extent of the disease. Intra- and interobserver variations in 
visual assessment were significant and limited the reliabili-
ty of this method. The involvement of “the human factor” is 
frequently responsible for over- or under- estimation of the 
total amount of emphysema in the lungs. It is also very dif-
ficult, based on information from CT, to estimate the total 
exact amount of emphysematous lung parenchyma and 
thus to assess visually the progression of the disease.
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This spurred the research looking for more objective meth-
ods for quantifying the total percentage of the lungs affect-
ed by emphysematous destruction. Since, the visual assess-
ment of emphysema is based on the presence of localized 
or diffuse areas of perceived low attenuation, which differ 
considerably from the remaining parenchyma, this differ-
ence in lung attenuation can be reliably quantitated by QCT.
Initially quantitative densitometry of the lung was depend-
ent on the measuring the mean value of pixel density in a 
particular area drawn in the region of interest (ROI) on each 
scan [5]. The normal lung density during full inspiration is 
between –750 to –850 Hounsfield units (HU) (on 10 mm slic-
es) and emphysema was considered to be present for values 
falling more than 2 SD below normal average density.
Based on the analysis of the frequency of attenuation values 
in the lung, the histogram can be created which displays the 
data as a distribution curve. The histogram represents the 
frequency distribution of pixels/voxels at different attenua-
tion intervals. In the normal lung (Figure 1), the attenuation 
values are most frequently distributed between –750 and 
–850 HU, with the peak attenuation centered at –789 HU. The 
abnormal accumulation of air in the non-functioning emphy-
sematous lung contributes to decreased lung density with 
shift of the lung attenuation values towards lower HU levels, 
below –900 (Figure 2). That makes the shift of the curve from 
the normal attenuation interval to the left which provides a 
visual index of the degree of emphysema. At that point other 
useful densitometric parameters can be calculated: mean lung 
attenuation (MLA) which is the average density of all pixels 
in the image representing the entire lung; the relative area 
of emphysema (RA)/emphysema index that is the area of the 
lung under the curve of the histogram occupied by attenu-
ation values lower than predetermined threshold [14,15]. In 
different studies, different thresholds were employed and val-
idated; the so called ‘percentile point’/’percentile density’ was 
described as a cutoff density value in HU, for which a prede-
termined percentage of all pixels has a lower value [16,17].
One of the first studies investigating the correlation 
between CT imaging (using the attenuation density values) 
and pathologic data in pulmonary emphysema was the 
study published in 1984 by Hayhurst et al. [7,18]. In a group 
of patients the author compared the CT images of patients’ 
lungs with measurements of the density of lung parenchyma 
with the resected lung specimens. The final conclusion of 
this study, after assessing the range of attenuation distribu-
tion values on CT scans, was that in patients with emphy-
sema, there were more attenuation values between –900 HU 
and –1000 HU than in normal individuals, which means that 
if a histogram plot was made of frequency against pixel den-
sity (HU), the distribution curve of these densities in emphy-
sema was shifted toward lower attenuation values compar-
ing to people without the disease (Figures 1, 2).
The histogram provides a means for interpreting pul-
monary densitometry when the predicted normal and 
observed curves are compared. The total lung volume can 
Figure 1.  Histogram in normal lung. The attenuation values are most 
frequently distributed between –750 and –850 HU.
Figure 2.  Histogram in emphysema. Emphysematous lung 
contributes to decreased lung density with the shift of the 
lung attenuation values towards lower HU levels.
Figure 3.  Emphysema. The total lung volume is assessed with 
the thresholds –1024 and –200 HU. Within this total 
lung volume, the functional lung parenchyma has the 
attenuation in range –700 to –900 HU. The non-functional 
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be assessed with the thresholds –1024 and –200 HU. Within 
the total lung volume, the functional lung parenchyma has 
the attenuation values in range –700 to –900 HU (Figure 3) 
and the non-functional lung parenchyma between –1024 
and –900 HU represents emphysema. The lung with attenu-
ation values greater than –700 HU has reduced participa-
tion in gas exchange. The lung volumes within these three 
attenuation intervals can be calculated to determine the 
contribution of each volume to the total lung function. The 
greater the proportion of lung attenuation values below 
–900 HU, the more extensive the emphysema.
The next step was taken in the study by Muller et al. [14] 
where the investigators used a CT scanner with a stand-
ard software program called “density mask”. That program 
highlights pixels with densities within a desired range, 
automatically calculates the area of highlighted pixels and 
then is able to express them as a percentage of the total 
pixels in a given area. Because the density of the emphy-
sematous lung parenchyma is abnormally low, by defining 
these areas of abnormally low attenuation values Muller 
et al. were able to quantify the extent and severity of 
emphysema. In that study the authors compared “density 
masks” and mean lung attenuation with subjective visual 
assessment and pathological score of resected lung speci-
men in order to determine the suitability of this program 
for assessment of emphysema. The best correlations were 
observed by highlighting all pixels with attenuation lesser 
or equal to –910 HU. The correlations between mask den-
sity score and the mask density percent area at the value 
lesser or equal to –910 HU with pathological score were 
0.94 and 0.89, respectively. In that particular study –910 
HU appeared to be the most reliable threshold and the best 
discrimination point between normal and emphysematous 
lung parenchyma. However, this value may vary for differ-
ent scanners and techniques but once estimated for partic-
ular settings it seems to remain stable. The study showed 
that the density mask allows objective quantification of the 
total lung volume showing emphysema on CT scans and the 
percentage of lung involved with emphysema.
Subsequent studies added even more information and ena-
bled even better use of those methods.
According to work undertaken by Gevenois et al. [15,19] 
–950 HU is the cut-off value for emphysematous lung 
parenchyma on CT scans which corresponds closely with 
macroscopic pathological measurements. Thresholds lower 
than –950 HU underestimated the presence of emphysema, 
whereas greater than –950 HU overestimated the disease. 
The researchers reported that based on their studies the 
relative area of the lung with attenuation values lower 
than –950HU on HRCT thin – sections scans taken at a 
full inspiration is very reliable way to objectively quantify 
macroscopic emphysema in vivo.
Currently, even more elaborated methods in quantifying 
emphysema are being investigated. These computer-assist-
ed methods rely on the advanced mathematic approaches 
called fractal dimensions. They help to better character-
ize examined tissue and thus allow easier differentiation 
between normal and emphysematous lung parenchyma. 
Studies conducted by Uppaluri et al. [20] and Mishima et al. 
[21] showed that fractal analysis is very promising, how-
ever this method still requires more research.
Comparison between CT quantification and PFTs
Pulmonary function tests (PFTs) are very important in the 
diagnosis and monitoring of emphysema. Their low costs, 
well-established correlation with clinical profile, reproduc-
ibility of results, the ability to predict prognosis and non-
utilization of ionization radiation give PFTs an advantage 
over the other methods [22]. However, there are several 
studies that show that PFTs have limitations especially in 
patients with less severe emphysema. The insensitivity 
of PFTs in detection early stages of emphysema was con-
firmed in the study conducted by Sanders et al. [23]. In this 
study the signs of emphysema on CT scans were observed 
not only in about 96% of patients who met the function-
al criteria of emphysema (decreased diffusing capacity of 
the lung for carbon monoxide (DLCO) and the presence of 
obstructive lung disease based on decreased forced expira-
tory volume in 1 second (FEV1) and/or increased residual 
volume (RV)) but also in 69% of smokers with completely 
normal DLCO. On the basis of these results authors con-
cluded that CT seems to be more precise in the diagnosis of 
the mild forms of emphysema. The associated insensitivity 
of PFTs probably can be explained by the lack of obstruc-
tive deficits (limitation of air-flow) in these patients, 
although the reduction of lung elastic recoil and increase 
in the lung size is present. Several other studies were con-
ducted in order to compare the quantitative CT analysis 
in emphysema with PFTs [24–28]. The evident correlation 
between PFTs and the total amount of emphysematous 
parenchyma has been shown as well as between PFTs and 
the distribution of these changes in the lungs. Emphysema 
in the lower lung zones seems to have higher correlations 
with DLCO comparing to lesions located in the upper parts. 
It is true even if the upper parts of the lungs are much 
more severely affected by the disease. Gurney et al. tried to 
explain this phenomenon stating that probably upper lung 
zones are relatively silent region where great emphysema-
tous destruction can be made before affecting functional 
tests whereas the presence and degree of emphysema in 
the lower lung zones has a stronger influence on the PFTs, 
because of loss of perfusion to the lower lobes. It also has 
been noticed that centrally located emphysema has high-
er correlations with PFTs than changes on the periphery 
of the lungs. Emerging 3D reconstructions of entire image 
data sets from spiral CT scans allowed more robust data 
processing with elimination of “regional sampling prob-
lems” created by investigation of limited number of slices. 
Through the comprehensive evaluation of the extent of 
emphysema, the correlation between CT analysis and PFTs 
could become even more precise [29].
As it was mentioned before the histogram position in 
respect to the attenuation intervals, its shape and symme-
try, as well as its peak provides important visual clues to 
the extent of emphysema.
The normal lung HRCT of a 19-year-old female is shown 
on Figure 4A. The histogram of this patient’s lung at –700 
HU threshold (Figure 4B) demonstrates that in the normal 
lung the attenuation values are most frequently distributed 
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between –750 and –850 HU. Only minimal volume of 10.18 
cc (mostly representing the trachea) was detected below 
–900 HU threshold. The emphysema index of this patient’s 
lung was estimated to be 0.2%.
On the other hand in the lungs with emphysema, the histo-
gram is shifted to the left, broad-based, frequently asym-
metric, and the peak is located below –850 HU. Figure 5A 
shows the HRCT image of a 62-year-old male with history 
of COPD and centrilobular and bullous emphysema.The his-
togram at –700 HU threshold (Figure 5B) presents a moder-
ate shift of the histogram peak to the left with significant 
increase in frequency of voxels with attenuation below 
–900 HU, representing a total volume of 1453.68 cc. The 
emphysema index of this patient’s lung is 22.5% and his 
FEV1/FVC demonstrated 53% of the predicted value.
Figure 6A,B reveal the HRCT and histogram of a 64-year-
old male with COPD and history of the left upper lobecto-
my. The histogram of this patient’s lung at –700 HU thresh-
old (Figure 6B) shows an extreme shift of the curve to the 
left, with the peak frequency distribution of lung voxels 
at attenuation level of –950 HU. The volume of the lung 
represented by voxels with attenuation below –900 HU 
is 2269.72 cc. His emphysema index was 41.9% and PFTs 
showed FEV1/FVC=31% of the predicted value.
These cases illustrate that there is a correlation between 
QCT of emphysema (e.g. histogram shape and emphysema 
index) and PFTs changes.
Comparison Between Subjective and Objective Methods 
of QCT
Both the subjective and objective methods of quantitative 
assessment of emphysema by CT have their pros and cons. 
Without doubt the major advantage of objective quantifi-
cation based on computer-assisted methods is the repro-
ducibility of the technique between different institutions 
and between different readers regardless of their expe-
rience. On the other hand, subjective methods are much 
easier to perform and do not require such an expensive 
software [30]. The comparison between subjective and 
objective methods of assessment of emphysema was con-
ducted by Bankier et al. [31]. He compared subjective vis-
ual grading of pulmonary emphysema with macroscopic 
morphometry and objective CT quantification. The study 
concluded that there was a weaker relationship between 
subjective visual assessment and the macroscopic data in 
comparison to the correlation between objective comput-
ed analysis and the morphological extent of emphysema. 
That is why it was recommended that subjective visual 
grading should be supplemented with objective methods 
Figure 4. Normal HRCT (A) and histogram (B) of a 19 year old female.
A
B
Figure 5.  HRCT (A) and histogram (B) of a 62 year old male with COPD 
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to achieve more precise, reader-independent quantifica-
tion of emphysema.
Technical Considerations in QCT
The density of the lung parenchyma within a given voxel 
is determined by the amount of air, tissue, interstitial fluid 
and blood [32].
There are multiple factors which might influence CT densi-
tometry (30):
a.  Respiratory status of the patient – inspiration vs. expi-
ration scans; some studies have investigated the possi-
bility of respiratory gating while performing CT scan-
ning in order to avoid possible errors due to differences 
in the lung volumes when breathing. Using spirometri-
cally triggered CT scanning, it was demonstrated [33] 
that in patients with emphysema the level of inspiration 
does not significantly influence the lung densitometry. 
However in healthy persons, the mean change in densi-
tometric parameters between 90% and 10% vital capacity 
is significant. Expiratory technique plays an important 
role in differentiating normal subjects from patients with 
chronic bronchitis in which air trapping can be detected 
only at 10% vital capacity. Inspiratory CT was found 
to be equal to expiratory CT in the ability to quantify 
abnormally low attenuation of the lung with pulmonary 
emphysema [34].
b.  Patient age – a study conducted by Soeijima et al. [35] 
showed that the percentage of RA960 (the relative area of 
lung occupied by attenuation values less than –960 HU) 
can increase with age, at least in the middle and lower 
lung zones.
c.  CT acquisition parameters – for example collimation, the 
amount of kilovoltage, reconstruction algorithm. In one 
study Mishima et al. [36] reported that three 2-mm thick 
CT sections, acquired with 200 or more mA tube current, 
are the most appropriate parameters to assess pulmo-
nary emphysema.
d.  Slice thickness, number and location of sections – 
because of the heterogeneous distribution of the emphy-
sema in the lungs, precise quantitative evaluation of 
the total lung emphysema cannot be obtained from the 
analysis of just a single or selected CT slices. However, 
concerns about radiation exposure make less slices more 
desirable than performing measurements in the whole 
lungs. Yet there are no established recommendations in 
regards to the minimal number of CT slices needed for 
accurate assessment of the severity of emphysema and 
the modern multidetector CT (MDCT) scanners rapidly 
acquire the entire lung volume.
e.  In spiral CT and multidetector CT (MDCT), the imag-
es are acquired during concurrent transport of the 
patient through the CT gantry at the constant speed 
when data is being collected continuously over multi-
ple gantry rotations/multiple detectors. The greatest 
advantages of spiral CT and MDCT is their ability to 
image the entire thorax during one single breath-hold. 
Since the acquisition of the entire volume of tissue is 
performed, density of three-dimensional voxels (vol-
ume elements) rather than two-dimensional pixels can 
be calculated. Using data collected with contemporary 
CT various 3D reconstructions can be created, lung vol-
umes measured and also, by interpreting the frequency 
distribution curve of attenuation values within these 
lung volumes, the quantification of different lung dis-
orders can be made. Specific protocols can be set-up 
with various attenuation thresholds to post-process the 
acquired data in an automated fashion to calculate spe-
cific volumes of interest and to modify the object selec-
tion parameters for additional threshold range adjust-
ments or subtractions. MDCT and 3D techniques can be 
particularly useful thanks to their ability to analyze the 
total lung in order to detect and assess the severity of 
the disease with heterogenous distribution among the 
lungs/lobes.
f.  Intravenous contrast administration – even though 
intravenous contrast increases the attenuation of nor-
mal lung parenchyma, it does not have a substantial 
effect on attenuation of the lung with emphysema. 
Emphysematous destruction results in hypovascu-
lar lung regions, therefore the influence of IV contrast 
administration is negligible in those areas. Thin colli-
mation and contrast may affect the absolute attenua-
tion numbers when a single slice is analyzed. However, 
with densitometry applied to the total lung volume, the 
quantitative assessment of emphysema is not affected 
[22,32].
Figure 6.  HRCT (A) and histogram (B) of a 64 year old male with 
COPD, after left upper lobectomy.
A
B
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CT quantification vs. Nuclear Medicine Studies
Scintigraphic studies have been useful in acquiring the 
information about the most severely affected by emphyse-
ma areas in the lung, as documented by some research con-
ducted on this subject [37–39]. Studies showed that func-
tional imaging with ventilation and perfusion lung scintig-
raphy (VQ scan) can be used to assess regional perfusion, 
ventilation and possible gas trapping [40]. Quantification 
is generally performed by dividing the lung into 3 zones: 
upper, middle and lower and then by calculating the per-
centage of ventilation and perfusion for each particular 
zone. A high-quality perfusion study is easily obtained 
with 99mTc-MAA. For more accurate estimate of the true 
ventilation the agent krypton-81m (81mKr) and Technegas 
can be used, however easier available Xenon-133 (133Xe) 
is used more frequently. In the future single photon emis-
sion computed tomography (SPECT) ventilation scans might 
be used instead of planar (2-dimensional) 133Xe imaging. 
Preliminary studies have shown that SPECT scanning after 
ventilation with Technegas and perfusion with 99mTc-MAA 
can provide detailed data about the most affected by the 
emphysema lung segments [41].
To date, CT still remains superior to scintigraphy in 
assessing the extent of the lung parenchyma destruction. 
However, scintigraphy might complement the CT data, espe-
cially regarding some additional physiologic information, for 
example on airway obstruction and regional gas trapping.
MRI in Emphysema
Magnetic Resonance (MR) is another modality that is being 
investigated for imaging and quantitation of emphysema. 
Until recently the lungs were not the most favorable organ to 
be examined using the magnetic field, but the use of hyper-
polarized noble gases as MR contrast agents has enabled bet-
ter visualization of lung parenchyma and has given research-
ers more detailed understanding of the structure and func-
tion of the lung. Hyperpolarized MR Diffusion Weighted 
Imaging gives information not only regarding static ven-
tilation of the lungs, but also provides data on ventilation 
dynamics, regional oxygen partial pressure and the appar-
ent diffusion coefficient (ADC) [42]. Among these parameters, 
ADC is the simplest quantitative marker to interpret.
The principle of DWI MRI with hyperpolarized gases is that 
diffusion of 3He atoms in the lung is determined by the size 
of the alveolar space and some studies have shown that in 
regions of emphysematous lung destruction, the ADC sig-
nificantly increases in comparison to healthy lungs [43–47]. 
Because of the high costs and limited supply of 3He, lung 
morphometry with hyperpolarized 129Xe was taken into 
consideration as an attractive alternative for clinical use 
[42,48,49]. Despite some differences between these two 
gases (lower gyromagnetic ratio, polarization and free dif-
fusion of 129Xe relative to 3He) hyperpolarized 129Xe ADC 
maps still show a meaningful correlation with PFTs, simi-
lar to what was shown using 3He [42]. Diffusion-weighted 
hyperpolarized MRI is a very sensitive method. It has been 
shown to be able to detect the early signs of emphysema, 
even when clinical signs are still absent [47,50]. The quan-
titative assessment of emphysema with hyperpolarized MR 
is possible by creating ADC map, that allows assessment 
of the size of the affected lung airspaces and also allows 
analysis of the location and severity of emphysema.
Therefore diffusion-weighted hyperpolarized MR could also 
become a useful imaging option in evaluation of this disease.
Conclusions
To date, quantitative assessment of emphysema using CT 
has been studied quite thoroughly. Unfortunately, this 
method is still not routinely used in the clinical prac-
tice, mostly because of its high costs, sophisticated image 
data processing, and radiation exposure. CT quantifica-
tion appears to be a robust tool to detect and monitor the 
severity of emphysema, especially in its early stages, with 
no evident clinical signs of the disease present. Also, pre-
cise quantitative evaluation of the extent of emphysema 
has been employed for treatment purposes, for example 
to assess the lung parenchyma during planning for lung 
volume reduction (LVR) procedures. LVR, by either surgi-
cal resection or bronchoscopic occlusion, is one of the most 
effective ways of therapy for patients with severe emphy-
sema [37]. The good results of this treatment are obtained 
by resection or occlusion of the most damaged and hyper-
inflated areas of the lungs. LVR significantly improves ven-
tilation/perfusion ratio in the remaining lung. In order for 
LVR to work properly it is crucial to precisely identify the 
most damaged fragments of the lung parenchyma (i.e. areas 
of gas trapping) [40]. Quantitative analysis of emphysema 
is not intended to replace direct observation and visual 
grading of CT scans by radiologists, but rather to comple-
ment the diagnostic information obtained by standard vis-
ual approach. 3D CT densitometry, a widely available tech-
nique for post-processing of CT imaging data, of the lungs 
may provide a useful, objective, and reproducible tool for 
the longitudinal follow-up of patients with emphysema 
and might become important in further defining the natu-
ral history of this disease and the rate of the lung destruc-
tion. The initial results from the conducted studies are very 
encouraging. However, the quantitative techniques have 
not yet been standardized and general guidelines for QCT 
are yet to be determined before these methods could be 
routinely used in clinical practice. The Radiologic Society 
of North America (RSNA) sponsored the Quantitative 
Imaging Biomarker Alliance (QIBA) that is currently 
working on validation and standardization of quantita-
tive methods for the assessment of COPD. QIBA's Chronic 
Obstructive Pulmonary Disease and Asthma Committee is 
defining the requirements for quantitative metrics for the 
evaluation of emphysema with CT, to include assessment 
of the precision and accuracy of phenotyping, and progres-
sion measurements in emphysema and asthma, to classify 
phenotype and assess longitudinal changes as medically 
meaningful surrogates for health status, and to compare 
the sensitivity of CT measurements to spirometry and 
other accepted measures. This will be necessary in order 
to determine if progressive disease can be detected signifi-
cantly sooner with quantitative imaging techniques than 
with currently accepted methods. Once the quantitative 
metrics are validated, further studies are needed to cor-
relate CT parameters with functional and histopathologic 
data and patients outcomes..
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